on S.M.A.I.O (isin : FR0014005I80)
SMAIO Reports Robust Sales Growth in 2025
SMAIO announced a notable 67% increase in its 2025 sales, reaching €9.2 million. This growth was driven by a significant 138% rise in U.S. sales, totaling €7 million. Excluding currency impacts, sales in U.S. dollars surged 160% to $7.9 million. This result underscores the growing adoption of SMAIO solutions among North American surgeons.
The company secured industrial partnerships for its KEOPS-4ME platform, aiming to launch patient-specific K-Rods on a larger scale in mid-2026. SMAIO closed 2025 with a solid cash position of €5.8 million. As SMAIO pursues further market penetration and technological advancements, the year 2026 is expected to continue this growth trajectory.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all S.M.A.I.O news